XML 14 R4.htm IDEA: XBRL DOCUMENT v3.22.2
Condensed Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Revenue:        
Total revenue $ 24,854 $ 23,873 $ 73,963 $ 81,165
Operating costs and expenses:        
Cost, Product and Service [Extensible Enumeration] Product Sales [Member] Product Sales [Member] Product Sales [Member] Product Sales [Member]
Product costs $ 5,141 $ 5,105 $ 14,745 $ 13,018
Research and development 12,975 12,246 38,350 36,003
Selling, general and administrative 12,854 7,885 33,159 22,815
Acquired intangible asset amortization 1,024 560 3,184 1,676
Acquisition transaction, integration and other costs   461   461
Contingent consideration expense 3   9  
Total operating costs and expenses 31,997 26,257 89,447 73,973
Operating (loss) income (7,143) (2,384) (15,484) 7,192
Other expense:        
Investment income, net 22 26 73 95
Interest expense (145) (59) (410) (178)
Foreign exchange gain (loss) 85 (94) 120 (201)
Other expense (38) (127) (217) (284)
(Loss) income before income taxes (7,181) (2,511) (15,701) 6,908
Income tax benefit (provision) 1,530 (776) 3,155 (2,382)
Net (loss) income $ (5,651) $ (3,287) $ (12,546) $ 4,526
Basic net loss (income) per share $ (0.41) $ (0.24) $ (0.90) $ 0.33
Diluted net loss (income) per share $ (0.41) $ (0.24) $ (0.90) $ 0.32
Weighted average number of shares outstanding:        
Basic 13,929 13,837 13,907 13,740
Diluted 13,929 13,837 13,907 13,959
Product Sales [Member]        
Revenue:        
Total revenue $ 13,919 $ 12,084 $ 40,227 $ 33,969
Royalties and License Fees [Member]        
Revenue:        
Total revenue 8,795 8,796 26,738 38,182
Research, Development and Other [Member]        
Revenue:        
Total revenue $ 2,140 $ 2,993 $ 6,998 $ 9,014